Genomic Health Inc. announced earnings results for the fourth quarter ended December 31, 2018. For the fourth quarter, the company announced total revenue was USD 104.609 million compared to USD 87.463 million a year ago. Operating income was USD 9.426 million compared to USD 2.150 million a year ago. Net income was USD 8.910 million compared to USD 1.879 million a year ago. Basic earnings per share was USD 0.25 compared to USD 0.05 a year ago. Diluted earnings per share was USD 0.23 compared to USD 0.05 a year ago. For the full year, total revenue was USD 394.111 million compared to USD 340.750 million a year ago. Operating income was USD 23.896 million compared to operating loss of USD 6.450 million a year ago. Net income was USD 25.677 million compared to net loss of USD 3.857 million a year ago. Basic earnings per share was USD 0.72 compared to basic loss per share of USD 0.11 a year ago. Diluted earnings per share was USD 0.68 compared to diluted loss per share of USD 0.11 a year ago.